NL7116577A - - Google Patents
Info
- Publication number
- NL7116577A NL7116577A NL7116577A NL7116577A NL7116577A NL 7116577 A NL7116577 A NL 7116577A NL 7116577 A NL7116577 A NL 7116577A NL 7116577 A NL7116577 A NL 7116577A NL 7116577 A NL7116577 A NL 7116577A
- Authority
- NL
- Netherlands
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19702059923 DE2059923C3 (de) | 1970-12-05 | 1970-12-05 | l-a-Isopropyl-o-[(N-methyl-N-homoveratryl)v-aminopropyl] -3,4-dimethoxyphenylacetonitril, Verfahren zu dessen Herstellung und dieses enthaltende Arzneimittel |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NL7116577A true NL7116577A (en:Method) | 1972-06-07 |
| NL172744B NL172744B (nl) | 1983-05-16 |
| NL172744C NL172744C (nl) | 1983-10-17 |
Family
ID=5790091
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL7116577A NL172744C (nl) | 1970-12-05 | 1971-12-02 | Werkwijze voor het bereiden van basisch gesubstitueerde fenylacetonitrile-verbindingen en deze verbindingen bevattende geneesmiddelen met een de coronaire doorstroming bevorderende activiteit. |
Country Status (8)
| Country | Link |
|---|---|
| AT (1) | AT305262B (en:Method) |
| BE (1) | BE776218A (en:Method) |
| CH (1) | CH565748A5 (en:Method) |
| DE (1) | DE2059923C3 (en:Method) |
| FR (1) | FR2116564B1 (en:Method) |
| GB (1) | GB1367677A (en:Method) |
| NL (1) | NL172744C (en:Method) |
| YU (2) | YU35346B (en:Method) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2946545A1 (de) | 1979-11-17 | 1981-05-27 | Basf Ag, 6700 Ludwigshafen | Verfahren zur gewinnung der enantiomeren formen von 4-cyan-1-(n-methyl-n-(2'-((3'',4'',-dimethoxyphenyl))-aethyl)-amino)-5-methyl-4-(3',4',5'-trimethoxyphenyl)-hexan und dessen salzen |
| DE3034221A1 (de) | 1980-09-11 | 1982-04-22 | Basf Ag, 6700 Ludwigshafen | Verfahren zur herstellung basisch substituierter phenylacetonitrile |
| DE3144150A1 (de) | 1981-04-10 | 1982-12-09 | Basf Ag, 6700 Ludwigshafen | (omega)-cyan-1,(omega)-diphenyl-azaalkan-derivate, ihre herstellung und diese enthaltende arzneimittel |
| DE3138488A1 (de) * | 1981-09-28 | 1983-04-14 | Knoll Ag, 6700 Ludwigshafen | Verwendung von basisch substituierten phenylacetonritrilen bei der vorbeugenden bekaempfung von krankheiten und mittel dafuer |
| DE3344755A1 (de) * | 1983-12-10 | 1985-06-20 | Basf Ag, 6700 Ludwigshafen | 1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan zur verwendung bei der bekaempfung von krankheiten |
| DE3635930A1 (de) * | 1986-10-22 | 1988-04-28 | Basf Ag | Wirkstoffe zur anwendung bei der behandlung von tumoren |
| DE3603660C2 (de) * | 1986-02-06 | 1994-09-15 | Fresenius Ag | Verbesserte Peritonealdialyse |
| DE4203547A1 (de) * | 1992-02-07 | 1993-08-12 | Knoll Ag | Verfahren zur racemattrennung von verapamil |
| GB9319918D0 (en) * | 1993-09-27 | 1993-11-10 | Chiros Ltd | Chiral compounds and their preparation |
| US5910601A (en) * | 1994-09-26 | 1999-06-08 | Darwin Discovery Limited | Chiral nitriles, their preparation and their use for the manufacture of verapamil and analogues |
| ATE198881T1 (de) * | 1996-02-08 | 2001-02-15 | Darwin Discovery Ltd | Trennung von 4-cyano-4-(3,4-dimethoxyphenyl)-5- methylexancarbonsäure |
| US5892093A (en) * | 1996-02-08 | 1999-04-06 | Darwin Discovery Limited | Resolution |
| AU3205497A (en) * | 1996-05-23 | 1997-12-09 | G.D. Searle & Co. | Pharmaceutical compositions containing non-racemic verapamil and process for optimizing the pharmaceutical activity of r- and s-verapamil |
| US5859279A (en) * | 1996-09-10 | 1999-01-12 | Darwin Discovery Limited | Compound and process |
| GB9618835D0 (en) * | 1996-09-10 | 1996-10-23 | Chiroscience Ltd | Process |
| EP1167348A4 (en) * | 1999-03-16 | 2002-11-13 | Eisai Co Ltd | nitrile |
| US6884791B2 (en) | 1999-07-06 | 2005-04-26 | Methylgene, Inc. | Inhibitors of β-lactamase |
| DE60024455T2 (de) | 1999-07-06 | 2006-08-03 | Methylgene, Inc., Saint-Laurent | Sulfonamidomethylphosphonat-BETA-LACTAMASE-Inhibitoren |
| BRPI0812919B8 (pt) | 2007-06-20 | 2021-05-25 | Milestone Pharmaceuticals Inc | composição farmacêutica que compreende um composto e kit |
| WO2016181292A1 (en) | 2015-05-12 | 2016-11-17 | Piramal Enterprises Limited | A process for the preparation of verapamil hydrochloride |
-
1970
- 1970-12-05 DE DE19702059923 patent/DE2059923C3/de not_active Expired
-
1971
- 1971-11-25 GB GB5472171A patent/GB1367677A/en not_active Expired
- 1971-11-26 CH CH1728771A patent/CH565748A5/xx not_active IP Right Cessation
- 1971-12-01 YU YU302371A patent/YU35346B/xx unknown
- 1971-12-01 AT AT1035371A patent/AT305262B/de not_active IP Right Cessation
- 1971-12-02 NL NL7116577A patent/NL172744C/xx not_active IP Right Cessation
- 1971-12-03 BE BE776218A patent/BE776218A/xx not_active IP Right Cessation
- 1971-12-06 FR FR7143744A patent/FR2116564B1/fr not_active Expired
-
1979
- 1979-02-01 YU YU21879A patent/YU35348B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| YU35346B (en) | 1980-12-31 |
| NL172744B (nl) | 1983-05-16 |
| NL172744C (nl) | 1983-10-17 |
| DE2059923A1 (de) | 1972-06-15 |
| CH565748A5 (en:Method) | 1975-08-29 |
| YU35348B (en) | 1980-12-31 |
| FR2116564B1 (en:Method) | 1975-03-14 |
| YU21879A (en) | 1980-06-30 |
| DE2059923C3 (de) | 1979-01-25 |
| DE2059923B2 (de) | 1978-05-18 |
| FR2116564A1 (en:Method) | 1972-07-13 |
| YU302371A (en) | 1980-06-30 |
| GB1367677A (en) | 1974-09-18 |
| BE776218A (fr) | 1972-06-05 |
| AT305262B (de) | 1973-02-26 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BB | A search report has been drawn up | ||
| BC | A request for examination has been filed | ||
| V4 | Lapsed because of reaching the maxim lifetime of a patent |